Jason T. Blackard, Ph.D. - Publications

Affiliations: 
2000 Harvard University, Cambridge, MA, United States 
Area:
Molecular Biology, Public Health

133 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Maunye TK, Gededzha MP, Blackard JT, Rakgole JN, Selabe SG. Hepatitis C virus genotype 5 variability in treatment naïve patients in South Africa. Intervirology. PMID 37231989 DOI: 10.1159/000528178  0.436
2023 Tyler B, Meeds HL, Odegard EA, Ismael N, Vubil A, Zicai AF, Mabunda N, Blackard JT. Hepatitis B Virus Genotype E/A Recombinants from Blood Donors in Beira, Mozambique. Microbiology Resource Announcements. e0018223. PMID 37227284 DOI: 10.1128/mra.00182-23  0.36
2023 Madhuravasal Krishnan J, Kong L, Karns R, Medvedovic M, Sherman KE, Blackard JT. The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines. Viruses. 15. PMID 37113007 DOI: 10.3390/v15041027  0.34
2023 Mathew A, Ismael N, Meeds H, Vubil A, Zicai AF, Mabunda N, Blackard JT. Hepatitis B virus genotypes and drug resistance mutations circulating in blood donors in Beira, Mozambique. Plos One. 18: e0281855. PMID 36795797 DOI: 10.1371/journal.pone.0281855  0.381
2022 Kong L, Shata MTM, Brown JL, Lyons MS, Sherman KE, Blackard JT. The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro. Journal of Neurovirology. PMID 35976538 DOI: 10.1007/s13365-022-01090-3  0.332
2021 Blackard JT, Sherman KE. Drugs of Abuse and Their Impact on Viral Pathogenesis. Viruses. 13. PMID 34960656 DOI: 10.3390/v13122387  0.399
2021 Olagbenro M, Anderson M, Gaseitsiwe S, Powell EA, Gededzha MP, Selabe SG, Blackard JT. In silico analysis of mutations associated with occult hepatitis B virus (HBV) infection in South Africa. Archives of Virology. PMID 34468889 DOI: 10.1007/s00705-021-05196-7  0.324
2021 Zimmerman J, Blackard JT. Human pegivirus type 1 infection in Asia-A review of the literature. Reviews in Medical Virology. e2257. PMID 34038600 DOI: 10.1002/rmv.2257  0.424
2021 Kong L, Karns R, Shata MTM, Brown JL, Lyons MS, Sherman KE, Blackard JT. The synthetic opioid fentanyl enhances viral replication in vitro. Plos One. 16: e0249581. PMID 33852610 DOI: 10.1371/journal.pone.0249581  0.393
2020 Phinius BB, Anderson M, Bhebhe L, Baruti K, Manowe G, Choga WT, Mupfumi L, Mbangiwa T, Mudanga M, Moyo S, Marlink R, Blackard JT, Gaseitsiwe S. Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana. Pathogens (Basel, Switzerland). 9. PMID 33202597 DOI: 10.3390/pathogens9110950  0.428
2020 Mabunda N, Zicai AF, Ismael N, Vubil A, Mello F, Blackard JT, Lago B, Duarte V, Moraes M, Lewis L, Jani I. Molecular and serological characterization of occult hepatitis B among blood donors in Maputo, Mozambique. Memorias Do Instituto Oswaldo Cruz. 115: e200006. PMID 32997000 DOI: 10.1590/0074-02760200006  0.33
2020 Baruti K, Lentz K, Anderson M, Ajibola G, Phinius BB, Choga WT, Mbangiwa T, Powis KM, Sebunya T, Blackard JT, Lockman S, Moyo S, Shapiro R, Gaseitsiwe S. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana. Plos One. 15: e0237252. PMID 32764801 DOI: 10.1371/Journal.Pone.0237252  0.443
2020 Ngwaga T, Kong L, Lin D, Schoborg C, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, King CC, Tavis JE, Blackard JT. Diversity of the hepatitis C virus NS5B gene during HIV co-infection. Plos One. 15: e0237162. PMID 32750098 DOI: 10.1371/Journal.Pone.0237162  0.583
2020 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses. 12. PMID 32640609 DOI: 10.3390/V12070731  0.419
2020 Lukhwareni A, Gededzha MP, Amponsah-Dacosta E, Blackard JT, Burnett RJ, Selabe SG, Kyaw T, Mphahlele MJ. Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans. Viruses. 12. PMID 32545313 DOI: 10.3390/V12060634  0.579
2020 Blackard JT, Davies SM, Laskin BL. BK polyomavirus diversity-Why viral variation matters. Reviews in Medical Virology. e2102. PMID 32128960 DOI: 10.1002/Rmv.2102  0.473
2020 Phinius BB, Anderson M, Bokete R, Mbangiwa T, Choga WT, Baruti K, Makhema J, Musonda R, Blackard JT, Essex M, Moyo S, Marlink R, Gaseitsiwe S. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana. Medicine. 99: e19341. PMID 32118769 DOI: 10.1097/Md.0000000000019341  0.678
2020 Raheel M, Choga WT, Blackard JT. The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape. Journal of Medical Virology. PMID 32104912 DOI: 10.1002/Jmv.25730  0.367
2019 Protopapas S, Murrison LB, Wexelblatt SL, Blackard JT, Hall ES. Addressing the Disease Burden of Vertically Acquired Hepatitis C Virus Infection Among Opioid-Exposed Infants. Open Forum Infectious Diseases. 6: ofz448. PMID 32128320 DOI: 10.1093/Ofid/Ofz448  0.494
2019 Hammerstad SS, Blackard JT, Lombardi A, Owen RP, Concepcion E, Yi Z, Zhang W, Tomer Y. Hepatitis C virus infection of human thyrocytes: metabolic, hormonal, and immunological implications. The Journal of Clinical Endocrinology and Metabolism. PMID 31784757 DOI: 10.1210/Clinem/Dgz241  0.52
2019 Blackard JT, Kong L, Rouster SD, Karns R, Horn PS, Kottilil S, Shata MT, Sherman KE. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. Plos One. 14: e0224523. PMID 31661521 DOI: 10.1371/Journal.Pone.0224523  0.554
2019 Bhebhe L, Anderson M, Souda S, Choga WT, Zumbika E, Shaver ZM, Mbangiwa T, Phinius BB, Banda CC, Melamu P, Musonda RM, Essex M, Blackard JT, Moyo S, Gaseitsiwe S. Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. Bmc Infectious Diseases. 19: 875. PMID 31640596 DOI: 10.1186/S12879-019-4514-1  0.625
2019 Blackard JT, Kwara A, Sherman KE. In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of Hepatology. PMID 31564447 DOI: 10.1016/J.Jhep.2019.07.010  0.368
2019 Boyce CL, Willis S, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT. Identification of hepatitis B virus genotype A/E recombinants in Ghana. Virus Genes. PMID 31346975 DOI: 10.1007/S11262-019-01690-Y  0.538
2019 Makatini Z, Mda S, Towobola O, Mthiyane H, Miles P, Blackard JT. Characterisation of protease resistance mutations in a South African paediatric cohort with virological failure, 2011 - 2017. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 109: 511-515. PMID 31266578 DOI: 10.7196/Samj.2019.V109I7.13705  0.431
2019 Baxter C, Ngcapu S, Blackard JT, Powell EA, Penton PK, Abdool Karim SS. Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis. Viruses. 11. PMID 31248149 DOI: 10.3390/V11060569  0.458
2019 Blackard JT, Brown JL, Lyons MS. Synthetic opioid use and common injection-associated viruses:expanding the translational research agenda. Current Hiv Research. PMID 31210115 DOI: 10.2174/1570162X17666190618154534  0.465
2019 Sherman KE, Rouster SD, Kong LX, Aliota MT, Blackard JT, Dean GE. Zika virus replication and cytopathic effects in liver cells. Plos One. 14: e0214016. PMID 30893357 DOI: 10.1371/Journal.Pone.0214016  0.42
2019 Mbangiwa T, Melamu P, Molebatsi K, Anderson M, Bhebhe L, Moyo S, Phinius B, Choga W, Blackard JT, Kasvosve I, Kammerer B, Mayondi G, Lockman S, Gaseitsiwe S. Maternal Hepatitis B Virus Infection, Pregnancy, and Infant Health Outcomes in Botswana Hepatitis Monthly. 19. DOI: 10.5812/Hepatmon.95569  0.399
2018 Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S. Molecular characterization of hepatitis B virus in blood donors in Botswana. Virus Genes. PMID 30382563 DOI: 10.1007/S11262-018-1610-Z  0.613
2018 Sherman KE, Abdel-Hameed E, Rouster SD, Shata MTM, Blackard JT, Safaie P, Kroner B, Preiss L, Horn PS, Kottilil S. Improvement in Hepatic Fibrosis Biomarkers Associated with Chemokine Receptor Inactivation through Mutation or Therapeutic Blockade. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239650 DOI: 10.1093/Cid/Ciy807  0.536
2018 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana. Genes. 9. PMID 30205537 DOI: 10.3390/Genes9090453  0.669
2018 Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S. In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm. Genes. 9. PMID 30134551 DOI: 10.3390/Genes9090420  0.532
2018 Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, et al. Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana. Genes. 9. PMID 29772814 DOI: 10.3390/Genes9050259  0.649
2018 Sherman KE, Rouster SD, Kong LX, Shata TM, Archampong T, Kwara A, Aliota MT, Blackard JT. Zika Virus Exposure in an HIV-Infected Cohort in Ghana. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29771784 DOI: 10.1097/Qai.0000000000001718  0.535
2018 Blackard JT, Sherman KE. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Reviews in Medical Virology. e1984. PMID 29761585 DOI: 10.1002/Rmv.1984  0.54
2018 N'Guessan KF, Boyce C, Kwara A, Archampong TNA, Lartey M, Sagoe KW, Kenu E, Obo-Akwa A, Blackard JT. Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Virus Genes. PMID 29551002 DOI: 10.1007/S11262-018-1555-2  0.591
2018 Gededzha MP, Sondlane TH, Malinga LA, Burnett RJ, Lebelo RL, Blackard JT, Mphahlele MJ, Selabe SG. Molecular characterization of hepatitis B virus X gene in HIV-positive South Africans. Virus Genes. PMID 29411271 DOI: 10.1007/S11262-018-1536-5  0.493
2018 Blackard JT. A39 Genetic diversity of the hepatitis C virus NS5B gene during HIV/HCV co-infection Virus Evolution. 4. DOI: 10.1093/Ve/Vey010.038  0.581
2017 Blackard JT, Kong L, Lombardi A, Homann D, Hammerstad SS, Tomer Y. A preliminary analysis of hepatitis C virus in pancreatic islet cells. Virology Journal. 14: 237. PMID 29258547 DOI: 10.1186/S12985-017-0905-3  0.504
2017 N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana. Open Forum Infectious Diseases. 4: ofx222. PMID 29255726 DOI: 10.1093/Ofid/Ofx222  0.632
2017 Bari K, Luckett K, Kaiser T, Diwan T, Cuffy M, Schoech M, Safdar K, Blackard JT, Apewokin S, Paterno F, Sherman KE, Zucker SD, Anwar N, Shah SA. Hepatitis C Transmission from Seropositive, Non-Viremic Donors to Non-Hepatitis C Liver Transplant Recipients. Hepatology (Baltimore, Md.). PMID 29205441 DOI: 10.1002/Hep.29704  0.436
2017 Singh S, Blackard JT. Human pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda. Reviews in Medical Virology. PMID 29148108 DOI: 10.1002/Rmv.1951  0.491
2017 Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 4: ofx195. PMID 29062862 DOI: 10.1093/Ofid/Ofx195  0.686
2017 Saha D, Pal A, Sarkar N, Das D, Blackard JT, Guha SK, Saha B, Chakravarty R. Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India. Plos One. 12: e0179035. PMID 28591184 DOI: 10.1371/Journal.Pone.0179035  0.569
2017 Boyce CL, Ganova-Raeva L, Archampong TNA, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Kwara A, Blackard JT. Identification and comparative analysis of hepatitis B virus genotype D/E recombinants in Africa. Virus Genes. PMID 28567562 DOI: 10.1007/S11262-017-1469-4  0.44
2017 Petronella Gededzha M, Mphahlele MJ, Blackard JT, Gloria Selabe S. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South Africans Hepatitis Monthly. 17. DOI: 10.5812/Hepatmon.14248  0.497
2016 Hammerstad SS, Stefan M, Blackard J, Owen RP, Lee HJ, Concepcion E, Yi Z, Zhang W, Tomer Y. HEPATITIS C VIRUS E2 PROTEIN INDUCES UPREGULATION OF IL-8 PATHWAYS AND PRODUCTION OF HEAT SHOCK PROTEINS IN HUMAN THYROID CELLS. The Journal of Clinical Endocrinology and Metabolism. jc20163403. PMID 27860532 DOI: 10.1210/Jc.2016-3403  0.476
2016 Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases. 3: ofw140. PMID 27800524 DOI: 10.1093/Ofid/Ofw140  0.688
2016 Woltmann J, Burke P, Brady R, Blackard JT. Demographics of Hepatitis C in Southwest Ohio (2010 to 2015). Hepatitis Monthly. 16: e37904. PMID 27799964 DOI: 10.5812/Hepatmon.37904  0.484
2016 Amponsah-Dacosta E, Rakgole JN, Gededzha MP, Blackard JT, Selabe SG, Mphahlele MJ. Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 27245151 DOI: 10.1016/J.Meegid.2016.05.035  0.559
2016 Archampong TN, Boyce CL, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Blackard JT, Kwara A. HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients. Antiviral Therapy. PMID 27167598 DOI: 10.3851/Imp3055  0.542
2016 Powell EA, Razeghi S, Zucker S, Blackard JT. Occult Hepatitis B Virus Infection in a Previously Vaccinated Injection Drug User. Hepatitis Monthly. 16: e34758. PMID 27148386 DOI: 10.5812/Hepatmon.34758  0.426
2016 Blackard JT, Ma G, Polen C, DuBois JC, Gast J, Radens CM, Sterling RK, Sherman KE. Recombination among GB virus C (GBV-C) isolates in the United States. The Journal of General Virology. PMID 27072634 DOI: 10.1099/Jgv.0.000477  0.486
2016 Powell EA, Boyce CL, Gededzha MP, Selabe SG, Mphahlele MJ, Blackard JT. Functional Analysis of "a" Determinant Mutations Associated with Occult HBV in HIV-Positive South Africans. The Journal of General Virology. PMID 27031988 DOI: 10.1099/Jgv.0.000469  0.451
2016 Prabdial-Sing N, Blackard JT, Puren AJ, Mahomed A, Abuelhassan W, Mahlangu J, Vermeulen M, Bowyer SM. Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa. Antiviral Research. 127: 90-8. PMID 26704023 DOI: 10.1016/J.Antiviral.2015.11.011  0.416
2016 Amponsah-Dacosta E, Rakgole JN, Gadedzaha M, Blackard J, Selabe S, Mphahlele J. Genetic variability and molecular evolution of Hepatitis B virus in HIV co-infected patients onlamivudine-based anti-retroviral therapy: a 5 year South African longitudinal study F1000research. 5. DOI: 10.7490/F1000Research.1111602.1  0.54
2016 Amponsah-Dacosta E, Selabe G, Gededzha M, Rakgole J, Blackard J, Mphahlele J. Genetic variability and molecular evolution of hepatitis B virus in HIV co-infected patients on lamivudine based anti-retroviral therapy: A 5 year longitudinal study International Journal of Infectious Diseases. 45: 456. DOI: 10.1016/J.Ijid.2016.02.966  0.542
2015 Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. Bmc Infectious Diseases. 15: 335. PMID 26268355 DOI: 10.1186/S12879-015-1096-4  0.675
2015 Amponsah-Dacosta E, Lebelo RL, Rakgole JN, Selabe SG, Gededzha MP, Mayaphi SH, Powell EA, Blackard JT, Mphahlele MJ. Hepatitis B virus infection in post-vaccination South Africa: occult HBV infection and circulating surface gene variants. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 63: 12-7. PMID 25600597 DOI: 10.1016/J.Jcv.2014.11.032  0.479
2015 Powell EA, Gededzha MP, Rentz M, Rakgole NJ, Selabe SG, Seleise TA, Mphahlele MJ, Blackard JT. Mutations associated with occult hepatitis B in HIV-positive South Africans. Journal of Medical Virology. 87: 388-400. PMID 25164924 DOI: 10.1002/Jmv.24057  0.484
2015 Anderson M, Gaseitsiwe S, Moyo S, Wessels MJC, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana Bmc Infectious Diseases. 15. DOI: 10.1186/s12879-015-1096-4  0.647
2015 Ryan K, Anderson M, Gaseitsiwe S, Blackard J. Occult and Chronic Hepatitis B in HIV-Positive Batswana Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.1231  0.524
2015 Sherman K, Kong L, Blackard J. P0906 : Inhibition of HCV replication by CCR5 blockade with cenicriviroc and maraviroc Journal of Hepatology. 62: S684. DOI: 10.1016/S0168-8278(15)31109-0  0.417
2014 Blackard JT, Ma G, Welge JA, King CC, Taylor LE, Mayer KH, Klein RS, Celentano DD, Sobel JD, Jamieson DJ, Gardner L. GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection. Plos One. 9: e114467. PMID 25493916 DOI: 10.1371/Journal.Pone.0114467  0.505
2014 Sherman KE, Guedj J, Shata MT, Blackard JT, Rouster SD, Castro M, Feinberg J, Sterling RK, Goodman Z, Aronow BJ, Perelson AS. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science Translational Medicine. 6: 246ra98. PMID 25101888 DOI: 10.1126/Scitranslmed.3008195  0.574
2014 Blackard JT, Ma G, Sengupta S, Martin CM, Powell EA, Shata MT, Sherman KE. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. Journal of Medical Virology. 86: 1332-41. PMID 24788693 DOI: 10.1002/Jmv.23968  0.577
2014 Kong L, Welge JA, Powell EA, Blackard JT. HIV infection of hepatocytes results in a modest increase in hepatitis C virus expression in vitro. Plos One. 9: e83728. PMID 24586227 DOI: 10.1371/Journal.Pone.0083728  0.578
2014 Gededzha MP, Selabe SG, Blackard JT, Kyaw T, Mphahlele MJ. Near full-length genome analysis of HCV genotype 5 strains from South Africa. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 21: 118-23. PMID 24220189 DOI: 10.1016/J.Meegid.2013.10.022  0.437
2014 Penton PK, Blackard JT. Analysis of HIV quasispecies suggests compartmentalization in the liver. Aids Research and Human Retroviruses. 30: 394-402. PMID 24074301 DOI: 10.1089/AID.2013.0146  0.434
2014 Anderson M, Gaseitsiwe S, Moyo S, Mohammed T, Sebunya TK, Blackard J, Makhema J, Essex M, Musonda R. Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana Bmc Infectious Diseases. 14. DOI: 10.1186/1471-2334-14-S2-P86  0.696
2013 Mayaphi SH, Martin DJ, Mphahlele MJ, Blackard JT, Bowyer SM. Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV Journal of Medical Virology. 85: 1883-1892. PMID 23925707 DOI: 10.1002/Jmv.23695  0.528
2013 Sengupta S, Powell E, Kong L, Blackard JT. Effects of HCV on basal and tat-induced HIV LTR activation. Plos One. 8: e64956. PMID 23762271 DOI: 10.1371/Journal.Pone.0064956  0.592
2013 Kong L, Blackard JT. Interferon alfa partially inhibits HIV replication in hepatocytes in vitro. The Journal of Infectious Diseases. 208: 865-6. PMID 23757338 DOI: 10.1093/Infdis/Jit255  0.473
2013 Blackard JT, Kong L, Huber AK, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid : Official Journal of the American Thyroid Association. 23: 863-70. PMID 23259732 DOI: 10.1089/Thy.2012.0507  0.494
2013 Blackard JT, Martin CM, Sengupta S, Forrester J. Limited infection with occult hepatitis B virus in drug users in the USA. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 43: 413-7. PMID 22909008 DOI: 10.1111/J.1872-034X.2012.01072.X  0.425
2012 Blackard JT. HCV superinfection and reinfection. Antiviral Therapy. 17: 1443-8. PMID 23221168 DOI: 10.3851/Imp2460  0.488
2012 Martin CM, Welge JA, Rouster SD, Shata MT, Sherman KE, Blackard JT. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. Journal of Viral Hepatitis. 19: 716-23. PMID 22967103 DOI: 10.1111/J.1365-2893.2012.01595.X  0.472
2012 Kong L, Cardona Maya W, Moreno-Fernandez ME, Ma G, Shata MT, Sherman KE, Chougnet C, Blackard JT. Low-level HIV infection of hepatocytes. Virology Journal. 9: 157. PMID 22877244 DOI: 10.1186/1743-422X-9-157  0.485
2012 Schwarze-Zander C, Blackard JT, Rockstroh JK. Role of GB virus C in modulating HIV disease. Expert Review of Anti-Infective Therapy. 10: 563-72. PMID 22702320 DOI: 10.1586/Eri.12.37  0.562
2012 Gededzha MP, Selabe SG, Kyaw T, Rakgole JN, Blackard JT, Mphahlele MJ. Introduction of new subtypes and variants of hepatitis C virus genotype 4 in South Africa. Journal of Medical Virology. 84: 601-7. PMID 22337299 DOI: 10.1002/Jmv.23215  0.465
2012 Blackard JT. HIV compartmentalization: a review on a clinically important phenomenon. Current Hiv Research. 10: 133-42. PMID 22329519 DOI: 10.2174/157016212799937245  0.493
2012 Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. Journal of Medical Virology. 84: 242-52. PMID 22170544 DOI: 10.1002/Jmv.22269  0.504
2011 Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. Aids Patient Care and Stds. 25: 571-7. PMID 21859307 DOI: 10.1089/Apc.2011.0106  0.541
2011 Martin CM, Welge JA, Blackard JT. Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons. Journal of Medical Virology. 83: 1142-50. PMID 21520141 DOI: 10.1002/Jmv.22090  0.556
2011 Blackard JT, Ma G, Martin CM, Rouster SD, Shata MT, Sherman KE. HIV variability in the liver and evidence of possible compartmentalization. Aids Research and Human Retroviruses. 27: 1117-26. PMID 21417757 DOI: 10.1089/Aid.2010.0329  0.457
2011 Neibecker M, Schwarze-Zander C, Rockstroh JK, Spengler U, Blackard JT. Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany. Journal of Medical Virology. 83: 685-94. PMID 21328384 DOI: 10.1002/Jmv.22029  0.435
2011 Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 674-80. PMID 21248367 DOI: 10.1093/Cid/Ciq199  0.586
2011 Schwarze-Zander C, Blackard JT, Spengler U, Rockstroh JK. A review of GB virus C co-infection in advanced HIV type-1 disease European Infectious Disease. 5: 27-30.  0.419
2010 Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman KE. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. Journal of Clinical Microbiology. 48: 4256-9. PMID 20810773 DOI: 10.1128/Jcm.01613-10  0.458
2010 Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, Kupfer B, Luechters G, Chung RT, Rockstroh JK, Spengler U. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antiviral Therapy. 15: 745-52. PMID 20710056 DOI: 10.3851/Imp1602  0.485
2010 Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. The Journal of Infectious Diseases. 201: 712-9. PMID 20105080 DOI: 10.1086/650490  0.575
2010 Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Journal of Viral Hepatitis. 17: 588-97. PMID 19889143 DOI: 10.1111/J.1365-2893.2009.01214.X  0.519
2009 Moreno-Fernandez ME, Zapata W, Blackard JT, Franchini G, Chougnet CA. Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain. Journal of Virology. 83: 12925-33. PMID 19828616 DOI: 10.1128/Jvi.01352-09  0.507
2009 Dryer PD, Limketkai BN, Martin CM, Ma G, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ, Blackard JT. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. The Journal of Antimicrobial Chemotherapy. 64: 945-8. PMID 19767319 DOI: 10.1093/Jac/Dkp328  0.461
2009 Blackard JT, Rouster SD, Nady S, Galal G, Marzuuk N, Rafaat MM, Daef E, El Din SS, Purcell RH, Emerson SU, Sherman KE, Shata MT. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 46: 140-4. PMID 19651539 DOI: 10.1016/J.Jcv.2009.07.007  0.496
2009 Martin CM, Welge JA, Shire NJ, Shata MT, Sherman KE, Blackard JT. Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine. 47: 194-8. PMID 19625194 DOI: 10.1016/J.Cyto.2009.06.005  0.464
2008 Akeno N, Blackard JT, Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. Journal of Autoimmunity. 31: 339-44. PMID 18799285 DOI: 10.1016/J.Jaut.2008.08.001  0.389
2008 Blackard JT, Welles SL, Ackerman A, Kalia N, Cohen DE, Mayer KH. Immunological rebound after initiation of highly active antiretroviral therapy in treatment-naive patients. Aids Research and Human Retroviruses. 24: 499-504. PMID 18373435 DOI: 10.1089/Aid.2007.0099  0.395
2008 Blackard JT, Sherman KE. HCV/HIV co-infection: Time to re-evaluate the role of HIV in the liver? Journal of Viral Hepatitis. 15: 323-330. PMID 18208497 DOI: 10.1111/J.1365-2893.2008.00970.X  0.613
2008 Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, Md.). 47: 321-31. PMID 18161707 DOI: 10.1002/Hep.21902  0.504
2007 Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinology and Metabolism Clinics of North America. 36: 1051-66; x-xi. PMID 17983936 DOI: 10.1016/J.Ecl.2007.07.001  0.373
2007 Blackard JT, Hiasa Y, Smeaton L, Jamieson DJ, Rodriguez I, Mayer KH, Chung RT. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. The Journal of Infectious Diseases. 195: 1765-73. PMID 17492592 DOI: 10.1086/518251  0.546
2007 Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 263-9. PMID 17477814 DOI: 10.1089/Jir.2006.0147  0.573
2007 Blackard JT, Sherman KE. Hepatitis C virus coinfection and superinfection. The Journal of Infectious Diseases. 195: 519-24. PMID 17230411 DOI: 10.1086/510858  0.508
2007 Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 309-14. PMID 17159656 DOI: 10.1097/Qai.0B013E31802E29A9  0.541
2006 Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 834-8. PMID 17115902 DOI: 10.1089/Jir.2006.26.834  0.503
2006 Lin W, Kim SS, Yeung E, Kamegaya Y, Blackard JT, Kim KA, Holtzman MJ, Chung RT. Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. Journal of Virology. 80: 9226-35. PMID 16940534 DOI: 10.1128/Jvi.00459-06  0.42
2006 Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. The Journal of Infectious Diseases. 194: 410-9. PMID 16845623 DOI: 10.1086/505713  0.577
2006 Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (Baltimore, Md.). 44: 15-22. PMID 16799966 DOI: 10.1002/Hep.21283  0.498
2006 Koulinska IN, Villamor E, Msamanga G, Fawzi W, Blackard J, Renjifo B, Essex M. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Research. 120: 191-8. PMID 16621098 DOI: 10.1016/J.Virusres.2006.03.007  0.616
2006 Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St Clair JB, Chapman S, Taylor LE, Paranhos-Baccalà G, Chung RT. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. Journal of Medical Virology. 78: 202-7. PMID 16372286 DOI: 10.1002/Jmv.20528  0.534
2006 Hiasa Y, Blackard JT, Lin W, Kamegaya Y, Horiike N, Onji M, Schmidt EV, Chung RT. Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication. Journal of Virological Methods. 132: 195-203. PMID 16313977 DOI: 10.1016/J.Jviromet.2005.10.014  0.486
2006 Shata M, Barrett A, Rouster S, Shire N, Blackard J, Atiq M, Engle R, Purcell R, Emerson S, Strickland G, Sherman K. P.312 Isolation and characterization of hepatitis E virus (HEV)-specific T cell clones from an asymptomatic HEV-exposed subject Journal of Clinical Virology. 36: S158. DOI: 10.1016/S1386-6532(06)80488-9  0.391
2005 Blackard JT, Smeaton L, Hiasa Y, Horiike N, Onji M, Jamieson DJ, Rodriguez I, Mayer KH, Chung RT. Detection of hepatitis C virus (HCV) in serum and peripheral-blood mononuclear cells from HCV-monoinfected and HIV/HCV-coinfected persons. The Journal of Infectious Diseases. 192: 258-65. PMID 15962220 DOI: 10.1086/430949  0.51
2005 Lin W, Choe WH, Hiasa Y, Kamegaya Y, Blackard JT, Schmidt EV, Chung RT. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology. 128: 1034-41. PMID 15825084 DOI: 10.1053/J.Gastro.2005.02.006  0.461
2005 Kamegaya Y, Hiasa Y, Zukerberg L, Fowler N, Blackard JT, Lin W, Choe WH, Schmidt EV, Chung RT. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology (Baltimore, Md.). 41: 660-7. PMID 15723444 DOI: 10.1002/Hep.20621  0.36
2004 Blackard JT, Yang Y, Bordoni P, Sherman KE, Chung RT. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. The Journal of Infectious Diseases. 189: 1472-81. PMID 15073685 DOI: 10.1086/382959  0.577
2004 Blackard JT, Mayer KH. HIV superinfection in the era of increased sexual risk-taking. Sexually Transmitted Diseases. 31: 201-4. PMID 15028931 DOI: 10.1097/01.Olq.0000118082.45312.1F  0.443
2003 Meyer-Olson D, Brady KW, Blackard JT, Allen TM, Islam S, Shoukry NH, Hartman K, Walker CM, Kalams SA. Analysis of the TCR beta variable gene repertoire in chimpanzees: identification of functional homologs to human pseudogenes. Journal of Immunology (Baltimore, Md. : 1950). 170: 4161-9. PMID 12682248 DOI: 10.4049/Jimmunol.170.8.4161  0.399
2003 ZANDER C, ANDERSEN J, BLACKARD J, LIN W, ZDUNEK D, HESS G, PETERS M, KOZIEL M, SHERMAN K, ROBBINS G. 1066 GB virus-C clearance is frequent in HIV/HCV co-infected patients receiving interferon and ribavirin treatment but does not adversely affect HIV-1 viremia: the adult ACTG A5071 study group Hepatology. 38: 669-669. DOI: 10.1016/S0270-9139(03)81104-7  0.572
2003 BLACKARD J. 629 Hepatitis C virus (HCV) diversity in HIV-HCV co-infected persons initiating antiretroviral therapy Hepatology. 38: 464-464. DOI: 10.1016/S0270-9139(03)80671-7  0.587
2003 KAMEGAYA Y, HIASA Y, ZUKERBERG L, FOWLER N, BLACKARD J, LIN W, SCHMIDT E, CHUNG R. 502 HCV core-E1-E2 acts as an HCC tumor accelerator through suppression of apoptosis Hepatology. 38: 401-401. DOI: 10.1016/S0270-9139(03)80544-X  0.346
2003 HIASA Y, BLACKARD J, KAMEGAYA Y, HORIIKE N, ONJI M, SCHMIDT E, CHUNG R. 415 Sustained, interferon-sensitive HCV replication in a cell-based HCV replication model using replication defective adenoviral vectors or stable cell lines expressing T7 polymerase Hepatology. 38: 360-360. DOI: 10.1016/S0270-9139(03)80458-5  0.423
2003 LIN W, HIASA Y, KAMEGAYA Y, BLACKARD J, ZANDER C, BECK G, SCHMIDT E, CHUNG R. 31 HCV expression inhibits interferon signaling in a cell-based HCV replication model Hepatology. 38: 170-170. DOI: 10.1016/S0270-9139(03)80074-5  0.422
2002 Blackard JT, Cohen DE, Mayer KH. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 1108-14. PMID 11915000 DOI: 10.1086/339547  0.463
2001 Blackard JT, Renjifo B, Fawzi W, Hertzmark E, Msamanga G, Mwakagile D, Hunter D, Spiegelman D, Sharghi N, Kagoma C, Essex M. HIV-1 LTR subtype and perinatal transmission. Virology. 287: 261-5. PMID 11531404 DOI: 10.1006/Viro.2001.1059  0.576
2000 Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, Essex M. Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. Virology. 274: 402-11. PMID 10964782 DOI: 10.1006/Viro.2000.0466  0.53
2000 Choudhury S, Montano MA, Womack C, Blackard JT, Maniar JK, Saple DG, Tripathy S, Sahni S, Shah S, Babu GP, Essex M. Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India Journal of Human Virology. 3: 35-43. PMID 10774805  0.534
1999 Renjifo B, Blackard JT, Klaskala W, Chaplin BR, Shah P, McLane MF, Barin F, Esparza J, Zelaya JE, Osmanov S, Soto R, Fernandez JA, Baum MK, Essex ME. HIV-1 subtype B in Honduras. Virus Research. 60: 191-7. PMID 10392727 DOI: 10.1016/S0168-1702(99)00014-3  0.581
1999 Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology. 254: 220-5. PMID 9986788 DOI: 10.1006/Viro.1998.9504  0.603
1998 Maeda N, Kawamura T, Hoshino H, Yamada N, Blackard J, Kushida S, Miyano-Kurosaki N, Yamamoto N, Makino K, Yokota T, Uchida K, Miwa M. Inhibition of human T-cell leukemia virus type 1 replication by antisense env oligodeoxynucleotide. Biochemical and Biophysical Research Communications. 243: 109-12. PMID 9473488 DOI: 10.1006/Bbrc.1997.8039  0.327
1997 Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. Journal of Virology. 71: 8657-65. PMID 9343223 DOI: 10.1128/Jvi.71.11.8657-8665.1997  0.612
Show low-probability matches.